Joined Aug 31 2010
I earned my Ph.D. with the late Paul Gross where I worked on novel routes to make c-glycosdies. I then went on into industry before eventually going to the dark side of business development. I am currently the Sr. Director of North America Sales & Business Development for Flamma. If you need help finding a CMO/CDMO, please feel free to reach out to me.
FLAMMA is a specialty pharmaceutical chemical manufacturer based in the Bergamo area (near Milano in Northern Italy) that was established in 1950.
FLAMMA specializes in the cGMP manufacture of active ingredients (NCEs and APIs) and intermediates for the pharmaceutical industry. Flamma has particular expertise in high value chiral materials specifically functional amino acid related materials although Flamma is not limited by these chemistries. Flamma also manufactures specialty compounds and advanced intermediates for the nutraceutical and cosmetic industries and has several generic products. Also, Flamma develops and produces related compounds classified as APIs and/or finished products for its customers.
FLAMMA has three manufacturing facilities- each with R&D labs. Both Italian locations (Chignolo & Isso) are cGMP facilities (capacities of 120 m3 and 130 m3, respectively) that are regularly inspected by the FDA and AIFA (the Italian Ministry of Health). Flamma’s Chinese facilities are located in Dalian, China (on the coast of China; ~1 hour flight from Seoul). The facilities feature a cGMP production plant (200 m3) as well as separate R&D labs.
Flamma leverages their 100% self-owned, self-managed facilities in China to deliver results. Flamma reliably supplies materials directly customers and/or they deliver materials (when required) to their cGMP facilities in Italy in order to deliver the customer’s compound on-time with the required specifications. Flamma offers cost-effective services to customers looking for a trusted partner within China who will deliver the quality that one expects.
As a fully integrated company, Flamma is well positioned to help move compounds quickly along their path taking into consideration all aspects along the course of the project.
Flamma can be of assistance for early stage pre-clinical development of small molecules (multi-kilo) as well as for large-scale commercial manufacturing (MT). With a total capacity of 450 m3, over 550 employees and the flexibility to use three different manufacturing sites and three different R&D labs, see why Flamma should be your next contract manufacturer.
FLAMMA- Where It Matters Most
Flamma attends a variety of industry events such as Informex, DCAT, ChemOutsourcing, and CPhI. Please contact Flamma to set a meeting and learn more about Flamma.